ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY CENTRAL LABORATORY conducted a clinical trial by administering SAC Calcium to COVID-19-infected patients for two weeks in March 2020.

The results showed that all indicators, including white blood cell count, CRP, and lymphocyte levels, were within normal ranges, and all patients tested negative for the COVID-19 virus.

This provides evidence that SAC Calcium normalizes the body’s immune response and enhances its defense against external pathogens.